The effects of Capsicum annuum supplementation on lipid profiles in adults with metabolic syndrome and related disorders: A systematic review and meta‐analysis of randomized controlled trials
The electiveness of Capsicum annuum supplementation in controlling dyslipidemia in adults has been unclear. Therefore, this meta‐analysis focuses on the relationship between C. annuum supplementation and lipid profile in adults with metabolic syndrome (MetS) and related disorders. PubMed, Scopus, IS...
Saved in:
Published in | Phytotherapy research Vol. 37; no. 9; pp. 3859 - 3866 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.09.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 0951-418X 1099-1573 1099-1573 |
DOI | 10.1002/ptr.7922 |
Cover
Summary: | The electiveness of
Capsicum annuum
supplementation in controlling dyslipidemia in adults has been unclear. Therefore, this meta‐analysis focuses on the relationship between
C. annuum
supplementation and lipid profile in adults with metabolic syndrome (MetS) and related disorders. PubMed, Scopus, ISI Web of Science, and the Cochrane Library were searched up to March 2021. Only randomized controlled trials (RCTs) studying the administration of
C. annuum
compared to control on lipid markers in adults with MetS and related disorders were examined. Pooled effect sizes were reported as weighted mean differences (WMDs) and 95% confidence intervals (CIs). The results of four eligible RCTs showed that
C. annuum
supplementation could significantly reduce total cholesterol (TC) (WMD: −4.98 mg/dL, 95% CI: −7.08 to −2.88,
p
≤ 0.001) levels, but did not regulate triglyceride, high‐density lipoprotein cholesterol, and low‐density lipoprotein cholesterol concentrations. In summary, the present findings suggest the beneficial effects of
C. annuum
supplementation on the reduction of plasma levels of TC. However, to draw a firm link between
C. annuum
supplementation and lipid profile, more trials with adequate sample sizes, specifically in subjects with dyslipidemia are warranted. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 ObjectType-Review-4 content type line 23 ObjectType-Undefined-3 |
ISSN: | 0951-418X 1099-1573 1099-1573 |
DOI: | 10.1002/ptr.7922 |